Active substances
Diphenhydramine + Menthol + Sodium citrate
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| DRAMYLIN PEDIATRIC SYRUP | 0.14,0.57,0.011 g,g,g | Syrup · Oral use | 1 Bottle | SAR 7.00 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
| DIPHELIN PAEDIATRIC SYRUP | Syrup · Oral use | 1 Bottle | SAR 4.00 | NCE · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Withdrawn by MAH · Not Marketed | |
| DIPHELIN- ADULTS SYRUP | Syrup · Oral use | 1 Bottle | SAR 5.90 | NCE · OTC | MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE COUGH; ALLERGIC CONJUCTIVITIS (AC); BACTERIAL TONSILLOPHARYNGITIS TREATMENT AND PREVENTION; RENAL TRANSPLANT; SCHIZOPHRENIA
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.